Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Cambridge, United States
Countries of investment
  • Spain
Investment stages
  • Pre-Seed
  • Seed
  • Series A
Industries
  • Sustainability
  • Health Tech
  • AI
  • Data
About
Catalys Pacific is a venture Capital firm that is dedicated to transforming life sciences innovation. The firm focuses on creating and investing in global biotech companies, particularly with transpacific partnerships betTheyen Japan and the United States. Catalys Pacific leverages an extensive global network and a strong local presence to access unique sourcing and early stage investment opportunities, aimed at maximizing therapeutic impact for patients and generating attractive returns for investors.
Min check size
$100K
Max check size
$38.9M
Fund size
NPS

Investment Thesis

They transform life sciences innovation by creating and investing in global biotech companies, focusing on transpacific partnerships betTheyen Japan and the United States.
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

Pathalys Pharma

Renalys Pharma

Arialys Therapeutics

Mineralys Therapeutics

Aculys Pharma

HilleVax

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp